An upside to Covid? Surely, we’re joking.
Surely, we aren’t.
For all the horror wrought by the coronavirus pandemic, there is some good news, too. Efforts to understand this novel virus and find a preventive vaccine have kick-started innovation all across the health-care spectrum, from biotechnology and drug development to diagnostics and patient care. Recent advances in technology, powered by computational biology and artificial intelligence, are driving the creation of new health-care companies and reshaping industry leaders—and promise rich rewards for investors in both.
That’s the message of this year’s health-care roundtable, whose panelists can barely contain their optimism about the revolution at hand. Yes, they agree, it could be another long and dreary year before a safe and durable Covid vaccine is ready for broad distribution. But the post-Covid world could see a panoply of brand-new tools to solve age-old problems like cancer, kidney disease, and genetic disorders, allowing scientists to target disease pathways that weren’t recognized or understood even a few years ago. Read more…..
Chart of the Day
Warren Buffett, Berkshire Hathaway Inc. chairman and chief executive officer, talks about his investment strategy, his new health-care venture and the state of the banking industry. He speaks with Bloomberg’s David Westin on “Bloomberg Markets.”